Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Silvestri

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The American Review of Respiratory Disease|November 1, 1975
Lack of effect of rifampin on the antibody response to a viral antigen in patients with tuberculosisL G Silvestri
Bollettino Chimico Farmaceutico|October 1, 1971
[Use of "norms" by authorities]L G Silvestri
Bollettino Chimico Farmaceutico|June 1, 1972
[Rifamycins: recent progress]L G Silvestri
Annual Review of Microbiology|January 1, 1972
Rifamycins: a general viewS Riva, L G Silvestri
European Journal of Biochemistry|March 17, 1975
Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycinsA M Fietta, L G Silvestri
The Journal of Antibiotics|May 1, 1976
Gardimycin, a new antibiotic from Actinoplanes. III. Biological propertiesV Arioli, M Berti, L G Silvestri
Intervirology|January 1, 1974
Activation of DNA polymerase of murine leukemia virus by rifamycin derivativesS Barlati, A Brega, L G Silvestri
Antimicrobial Agents and Chemotherapy|August 1, 1974
Distribution in nature of R factors that increase susceptibility to rifampin of rif-r mutants in Escherichia coliR Scotti, L G Silvestri, E Romero
Biochemical and Biophysical Research Communications|December 4, 1972
Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicinS Riva, A Fietta, L G Silvestri
The American Review of Respiratory Disease|December 1, 1976
Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatmentL Di Berardino, G Perna, L G Silvestri
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The American Review of Respiratory Disease|November 1, 1975
Lack of effect of rifampin on the antibody response to a viral antigen in patients with tuberculosisL G Silvestri
Bollettino Chimico Farmaceutico|October 1, 1971
[Use of "norms" by authorities]L G Silvestri
Bollettino Chimico Farmaceutico|June 1, 1972
[Rifamycins: recent progress]L G Silvestri
Annual Review of Microbiology|January 1, 1972
Rifamycins: a general viewS Riva, L G Silvestri
European Journal of Biochemistry|March 17, 1975
Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycinsA M Fietta, L G Silvestri
The Journal of Antibiotics|May 1, 1976
Gardimycin, a new antibiotic from Actinoplanes. III. Biological propertiesV Arioli, M Berti, L G Silvestri
Intervirology|January 1, 1974
Activation of DNA polymerase of murine leukemia virus by rifamycin derivativesS Barlati, A Brega, L G Silvestri
Antimicrobial Agents and Chemotherapy|August 1, 1974
Distribution in nature of R factors that increase susceptibility to rifampin of rif-r mutants in Escherichia coliR Scotti, L G Silvestri, E Romero
Biochemical and Biophysical Research Communications|December 4, 1972
Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicinS Riva, A Fietta, L G Silvestri
The American Review of Respiratory Disease|December 1, 1976
Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatmentL Di Berardino, G Perna, L G Silvestri
Pageof 3